Hepatitis B virus-specific effector CD8+ T cells are an important determinant of disease prognosis: A meta-analysis.
CONCLUSION: HBV-specific effector CD8+ T cells influence the disease activity in HBV-infected patients in various ways and determine prognosis by eliminating the virus. Therefore, efforts of studying HBV-specific effector CD8+ T cells focused vaccine are potentially needed.
PMID: 30935741 [PubMed - as supplied by publisher]
Source: Vaccine - Category: Allergy & Immunology Authors: Zheng J, Ou Z, Xu Y, Xia Z, Lin X, Jin S, Liu Y, Wu J Tags: Vaccine Source Type: research
More News: Allergy & Immunology | Databases & Libraries | Hepatitis | Hepatitis B | Hepatitis Vaccine | Science | Statistics | Study | Vaccines